1 week ARS Pharma Retakes Its 50-Day Line In Bullish Post-Earnings Move. Here’s Why. Investor's Business Daily
Shares of ARS Pharmaceuticals bounded higher Thursday after the company reported an unexpected fourth-quarter metrics.
The post ARS Pharma Retakes Its 50-Day Line In Bullish Post-Earnings Move. Here's Why. appeared first on Investor's Busines…